In a prospective study we examined 38 patients with primary bronchogenic carcinoma to validate the use of indium-111 pentetreotide (IPT) as a diagnostic tool. Of these 38 patients, 25 had small cell lung cancer (SCLC) and 13, non-small cell lung cancer (NSCLC). The aim of the study ...
别名 INDIUM IN-111 PENTETREOTIDE KIT;OCTREOSCAN;MP-1727;INDIUM IN-111 PENTETREOTIDE KIT [ORANGE BOOK];111INDIUM PENTETREOTIDE;(SUP 111)INDIUM PENTETREOTIDE;PENTETREOTIDE 111IN CHELATE;PENTETREOTIDE 111IN CHELATE [MI];INDIUM IN 111 PENTETREOTIDE;INDIUM IN 111 PENTETREOTIDE [USAN] 扩...
We evaluated In-pentetreotide scintigraphy in the initial staging of 19 patients with histologically proven small-cell lung cancer (SCLC). Scintigraphy was also compared to the results of conventional imaging. Images performed during initial staging demonstrated 21 known pulmonary lesions and 2 known ...
In a prospective study we examined 38 patients with primary bronchogenic carcinoma to validate the use of indium- I 11 pentetreotide (IPT) as a diagnostic tool. Of these 38 patients, 25 had small cell lung cancer (SCLC) and 13, non-small cell lung cancer (NSCLC). The aim of the study...
戊戌数据药品标准数据库提供了Indium In 111 Pentetreotide Injection美国药典标准的查询检索,包括Indium In 111 Pentetreotide Injection美国药典的版本USP-NF 2023页码,以及药典的查询与下载.
VIP 数据库导航 当前位置: 首页 > 药物分子靶点 > Indium In-111 pentetreotide 反馈纠错帮助中心打印 扩展信息
基本信息 标准 美国药典 版本 usp35-nf30 来源 分类 usp 页码 3495 usp 35official monographs / indocyanine 3495 counts for the 111 in pentetreotide, unbound 111 in, other impuritylabeling—label it to include the following, in addition to the peaks, and a representative baseline segment, and ...
PREDICTIVE POWER AND LIMITATIONS OF THE DIAGNOSTIC SCAN FOR INDIUM-111 PENTETREOTIDE THERAPYAn abstract is unavailable.doi:10.1097/00003072-199903000-00032L. LemenJ. NelsonG. EspenanK. E. McCarthyE. A. WolteringOvid Technologies (Wolters Kluwer Health)Clinical Nuclear Medicine...
Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Bone metastases are assumed to be rare in carcinoid disease and to be associated mainly with bronchial primaries. The aim of the present study...
Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors. Well-differentiated metastatic endocrine carcinomas are difficult to manage because of variable disease outcome. New prognostic factors are required. ...